HomeAI · summaries
Storia in 2 fonti
Emcure Pharma Q1 profit jumps 36%, revenue rises 23%; appoints Samit Mehta as COO
"We have begun FY27, the second year of our five-year plan—on a strong footing. FY26 was about putting the building blocks in place across teams, portfolio, integration and operating discipline. FY27 is about delivery, and Q1 is an encouraging early signal,” said Satish Mehta, Managing Director and CEO Emcure Pharmaceuticals.
Confronto fonti
2 prospettive sulla stessa storiaTimeline cronologica
- ·
thehindubusinessline.com
Emcure Pharmaceuticals Q1 profit rises 36% at ₹292.5 crore
Emcure Pharmaceuticals reports a 36% profit increase to ₹292.5 crore in Q1, driven by strong international business growth.
- ·
economictimes.indiatimes.com
Emcure Pharma Q1 profit jumps 36%, revenue rises 23%; appoints Samit Mehta as COO
"We have begun FY27, the second year of our five-year plan—on a strong footing. FY26 was about putting the building blocks in place across teams, portfolio, integration and…
